Cancer Spit Test Device Market – Non-Invasive Early...

ha aggiunto una foto Altre informazioni

2026-01-16 12:13:35 -

Cancer Spit Test Device Market – Non-Invasive Early Detection, Liquid Biopsy Innovation & Diagnostic Accessibility

Executive Summary The Cancer Spit Test Device Market represents a high-growth frontier in the oncology diagnostics sector, driven by the shift toward non-invasive, patient-centric screening solutions. Saliva-based diagnostics, or "salivaomics," leverage biomarkers such as circulating tumor DNA (ctDNA), transcripts (mRNA), and proteins to detect malignancies—particularly oral,...

0 Commenti 0 condivisioni 17 Views 0 Anteprima